|
|
|
 |
FDA Approval Activities for this Drug…
Serevent (Salmeterol Xinafoate) Inhalation Aerosol, GlaxoSmithKline NDA 20-236/S28 8/11/03 8/15/03 8/15/03 Serevent (Salmeterol Xinafoate) Glaxo Wellcome 020236 12/24/98 8/7/03 | Serevent Diskus (salmeterol xinafoate inhalation powder), GlaxoSmithKline NDA 20-692/S-024 8/11/03 8/15/03 8/15/03 | Serevent Diskus (salmeterol xinafoate inhalation powder), GlaxoSmithKline NDA 20-692/S-016 3/22/02 4/8/02 3/25/02 | Serevent Diskus (salmeterol xinafoate inhalation powder) Glaxo Wellcome NDA 20-692/S-001 S-002 9/25/98 9/28/98 9/28/98 5/17/01 | Servent Indications: Supplement S-001 is indicated for the use of Serevent Diskus for the treatment of exercise-induced bronchospasm in patients 4 years of age and older. | Supplement S-002 is indicated for the use of Serevent Diskus for the maintenance treatment of asthma and prevention of bronchospasm. | Serevent Diskus (salmeterol xinafoate inhalation powder), GlaxoSmithKline, Labeling Revision | Advair Diskus (fluticasone propionate and salmeterol inhalation powder), GlaxoSmithKline, Labeling Revision | Serevent Diskus (salmeterol xinafoate inhalation powder), GlaxoSmithKline, Labeling Revision | Advair HFA (fluticasone propionate and salmeterol xinafoate) Inhalation Aerosol, GlaxoSmithKline, Approval | Advair Diskus (fluticasone propionate and salmeterol xinafoate) inhalation powder, GlaxoSmithKline, Labeling Revision | Advair Diskus (fluticasone propionate and salmeterol inhalation powder), GlaxoSmithKline, Labeling Revision | Serevent Diskus (salmeterol xinafoate inhalation powder), GlaxoSmithKline, Labeling Revision | Advair HFA (fluticasone propionate and salmeterol xinafoate) Inhalation Aerosol, GlaxoSmithKline, Labeling Revision | Serevent (salmeterol xinafoate) Inhalation Powder, GlaxoSmithKline, Labeling Revision | Advair Diskus 100/50 (fluticasone propionate and salmeterol xinafoate) Inhalation Powder, GlaxoSmithKline, New Dosage Regimen | Advair Diskus 250/50 (fluticasone propionate and salmeterol xinafoate) Inhalation Powder, GlaxoSmithKline, New Dosage Regimen | Advair Diskus 500/50 (fluticasone propionate and salmeterol xinafoate) Inhalation Powder, GlaxoSmithKline, New Dosage Regimen | Advair HFA (fluticasone propionate and salmeterol xinafoate) Inhalation Aerosol, GlaxoSmithKline, Labeling Revision | Serevent (salmeterol xinafoate) Inhalation Powder, GlaxoSmithKline, Labeling Revision | Serevent (salmeterol xinafoate) Inhalation Powder, GlaxoSmithKline, Labeling Revision | Serevent (salmeterol xinafoate) Inhalation Powder, GlaxoSmithKline, Labeling Revision
  
|